San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, Cellular Longevity dba Loyal is raising $28,831,521.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Celine Halioua played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Cellular Longevity dba Loyal
We are a team of veterinarians, scientists, and dog lovers devoted to developing medicines intended to treat the underlying causes of aging in dogs. Our scientists educational backgrounds span academic institutions including Cornell Universitys College of Veterinary Medicine and Oxford University and industry expertise in developing therapeutic candidates with Regeneron and Zoetis.

To learn more about Cellular Longevity dba Loyal, visit http://loyalfordogs.com/

Contact:
Celine Halioua, Chief Executive Officer
408-757-0450
celine@loyalfordogs.com
https://www.linkedin.com/in/celinehh/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved